VR Adviser, LLC
- SEC CIK
- 0001615982
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 35
- −3 vs. Q1 2024
- Portfolio value
- $1.57B
- −$532.0M (−25.3%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CASIFCASI Pharmaceuticals, Inc. | ORD SHS | 111,686 | $614.3K | <0.1% | +111,686 | New | History |
| ORKAOruka Therapeutics, Inc. | COM | 866,375 | $3.32M | 0.2% | +866,375 | New | History |
| TNYATenaya Therapeutics, Inc. | COM | 1,555,556 | $4.82M | 0.3% | 00.0% | Unchanged | History |
| FRNMFreenome, Inc. | CL A ORD SHS | 750,000 | $7.54M | 0.5% | +750,000 | New | History |
| ADVMAdverum Biotechnologies, Inc. | COM NEW | 1,467,048 | $10.1M | 0.6% | −89,371−5.7% | Reduced | History |
| TRVITrevi Therapeutics, Inc. | COM | 3,422,637 | $10.2M | 0.6% | −380.0% | Reduced | History |
| CABACabaletta Bio, Inc. | COM | 1,563,952 | $11.7M | 0.7% | 00.0% | Unchanged | History |
| IPSCCentury Therapeutics, Inc. | COM | 5,389,259 | $13.7M | 0.9% | +1,984,126+58.3% | Added | History |
| AQSTAquestive Therapeutics, Inc. | COM | 5,555,555 | $14.4M | 0.9% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 627,788 | $16.7M | 1.1% | 00.0% | Unchanged | History |
| ABVXAbivax S.A. | SPONSORED ADS | 1,345,780 | $17.8M | 1.1% | 00.0% | Unchanged | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 9,000,000 | $20.2M | 1.3% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 6,023,166 | $21.1M | 1.3% | +6,023,166 | New | History |
| MRSNMersana Therapeutics, Inc. | COM | 11,328,000 | $22.8M | 1.5% | 00.0% | Unchanged | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 3,410,058 | $23.2M | 1.5% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,379,965 | $24.1M | 1.5% | +1,379,965 | New | History |
| ENGNenGene Therapeutics Inc. | COM | 2,825,983 | $26.6M | 1.7% | +260,142+10.1% | Added | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 706,131 | $29.2M | 1.9% | +50.0% | Added | History |
| ORICOric Pharmaceuticals, Inc. | COM | 4,394,527 | $31.1M | 2.0% | 00.0% | Unchanged | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,818,182 | $32.7M | 2.1% | 00.0% | Unchanged | History |
| ATXSAstria Therapeutics, Inc. | COM | 3,608,645 | $32.8M | 2.1% | 00.0% | Unchanged | History |
| ERASErasca, Inc. | COM | 16,216,216 | $38.3M | 2.4% | +16,216,216 | New | History |
| APLTApplied Therapeutics, Inc. | COM | 9,542,871 | $44.6M | 2.8% | +467,871+5.2% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 5,684,167 | $47.9M | 3.1% | +555,000+10.8% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 3,882,671 | $50.5M | 3.2% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 2,094,373 | $54.2M | 3.5% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 2,685,448 | $63.1M | 4.0% | +513,666+23.7% | Added | History |
| PHVSPharvaris N.V. | COM | 3,395,606 | $63.8M | 4.1% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 6,249,731 | $73.6M | 4.7% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 1,263,214 | $74.7M | 4.8% | −527,000−29.4% | Reduced | History |
| DYNDyne Therapeutics, Inc. | COM | 2,173,913 | $76.7M | 4.9% | 00.0% | Unchanged | History |
| OCULOcular Therapeutix, Inc | COM | 12,762,462 | $87.3M | 5.6% | 00.0% | Unchanged | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 4,400,000 | $92.4M | 5.9% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 4,026,331 | $94.1M | 6.0% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 8,493,321 | $334.2M | 21.3% | 00.0% | Unchanged | History |
Sold out since Q1 2024 (9)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| HLVXHilleVax, Inc. | COM | 2,075,000 | $34.5M | 1.6% | History |
| CELCCelcuity Inc. | COM | 970,000 | $21.0M | 1.0% | History |
| IMTXImmatics N.V. | SHS | 1,750,000 | $18.4M | 0.9% | History |
| LYRALyra Therapeutics, Inc. | COM | 2,576,093 | $16.0M | 0.8% | History |
| CGONCG Oncology, Inc. | COM | 350,000 | $15.4M | 0.7% | History |
| MLYSMineralys Therapeutics, Inc. | COM | 555,554 | $7.17M | 0.3% | History |
| SLRNACELYRIN, Inc. | COM | 937,113 | $6.33M | 0.3% | History |
| EYPTEyePoint, Inc. | COM NEW | 250,000 | $5.17M | 0.2% | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 77,042 | $872.1K | <0.1% | History |